Join us in Mission Bay #SanFrancisco again at @HarmonicBrewing Dec. 2 2024 for our patent-pending Scientific Speed #Networking! #drugdiscovery #drugdevelopment #genomics #medicaldevice

VSP Vision COO Earnie Franklin dies of cancer at 61 #biotech #news

RAINFALL HEALTH ANNOUNCES INAUGURAL COMMITTEE WITH HEALTHCARE LEADERS IN AN UNPRECEDENTED MOVE TOWARD STANDARDIZING HEALTH CARE DELIVERY ACROSS THE COUNTRY #news #biotech

Peninsula biotech sheds 60% of its value as it pauses key clinical trial #biotech #news

Rondo Therapeutics Presents Preclinical Data at ASCO GU for its Novel CD28 x Nectin-4 Costimulatory Bispecific Antibody for Advanced Bladder Cancer #news #biotech

24,000 Registered Attendees Fill the Halls of Successful SPIE Photonics West 2025 #biotech #news

Gravie Names Steve Wolin Chief Executive Officer #news #biotech

IgGenix to Present Alpha-gal Syndrome Monoclonal Antibody Discovery at 2025 AAAAI / WAO Joint Congress #news #biotech

Medallion CEO and Founder Derek Lo Recognized as One of Modern Healthcare’s 40 Under 40 #biotech #news

Workday Named Best in KLAS for ERP (Large) for the Eighth Consecutive Year #biotech #news

SandboxAQ Expands Alliance with Deloitte to Offer AI Simulation Software Solutions #biotech #news

Pliant pauses phase 2 lung fibrosis trial on advice of safety committee #biotech #news

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis #news #biotech

Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger #news #biotech

StockWatch: Illumina Tumbles on Q4 Results, China Retaliation #biotech #news

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program #news #biotech

AceLink Therapeutics Presents Interim Results from a Phase 2 Trial of the GCS Inhibitor AL01211 in Treatment-Naïve, Classic Male Fabry Disease Patients at the WORLD Symposium 2025 #biotech #news

23andMe’s Anne Wojcicki open (again) to third-party buyout of genetic testing company #biotech #news

After big IPO, Peninsula biotech plots merger, big clinical trial readouts #biotech #news

Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia #biotech #news

Acelyrin to be absorbed into Alumis in all-stock merger #biotech #news